🇺🇸 FDA
Patent

US 10494364

Cathepsin K inhibitors and application thereof

granted A61KA61K31/275A61K31/343

Quick answer

US patent 10494364 (Cathepsin K inhibitors and application thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/275, A61K31/343, A61K31/351, A61K31/357